This topic contains a solution. Click here to go to the answer

Author Question: You have a patient recently diagnosed with osteoporosis and achlorydria. Your primary concern ... (Read 45 times)

cabate

  • Hero Member
  • *****
  • Posts: 537
You have a patient recently diagnosed with osteoporosis and achlorydria. Your primary concern regarding recommending calcium supplements is:
 a. the decreased absorption due to the lack of HCl secretion.
  b. the increased absorption due to the excess secretion of HCl.
  c. the decreased absorption due to excess secretion of HCl.
  d. the increased absorption due to the lack of HCl secretion.

Question 2

Long-term use of corticosteroids can have which of the following effects?
 a. high cholesterol
  b. osteoporosis
  c. ulcers
  d. high blood pressure



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

micaelaswann

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

a

Answer to Question 2

b





 

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

The cure for trichomoniasis is easy as long as the patient does not drink alcoholic beverages for 24 hours. Just a single dose of medication is needed to rid the body of the disease. However, without proper precautions, an individual may contract the disease repeatedly. In fact, most people develop trichomoniasis again within three months of their last treatment.

Did you know?

The first war in which wide-scale use of anesthetics occurred was the Civil War, and 80% of all wounds were in the extremities.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library